Adolescent-Onset and Adult-Onset Vitamin-Responsive Neurogenetic Diseases: A Review.


Journal

JAMA neurology
ISSN: 2168-6157
Titre abrégé: JAMA Neurol
Pays: United States
ID NLM: 101589536

Informations de publication

Date de publication:
01 04 2021
Historique:
pubmed: 12 1 2021
medline: 11 1 2022
entrez: 11 1 2021
Statut: ppublish

Résumé

Vitamin-responsive inherited diseases are among the rare genetic disorders with a specific pharmacological treatment. Many of these conditions have a prominent neurological phenotype that is mainly reported in children. Being rare and often strikingly different in adult-onset forms, they are still poorly known in the medical fields specific to adults. This article reviews all articles reporting cases of patients with a genetically confirmed inherited vitamin-responsive neurological disease and neurological onset after the age of 10 years. On this basis, 24 different diseases are described, involving vitamins A, B1, B2, B3, B6, B8, B9, B12, E, and tetrahydrobiopterin (BH4). Information such as clinical symptoms, disease course, imaging studies, biochemical alterations, and response to treatment present an overall picture of these patients. Vitamin-responsive neurogenetic diseases represent a group of rare conditions that are probably underdiagnosed in adults and may have a dramatic response to treatment when started early in the course of the disease. In this review, main features of the adult-onset forms are defined and simple key messages are provided to help identify clinical situations when specific diagnostic tests should be performed and/or vitamins should be promptly administered.

Identifiants

pubmed: 33427863
pii: 2774468
doi: 10.1001/jamaneurol.2020.4911
doi:

Substances chimiques

Vitamin A 11103-57-4
Vitamin B Complex 12001-76-2
Vitamin E 1406-18-4

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

483-490

Auteurs

Daniele Mandia (D)

Neuro-Metabolism Unit, Reference Center for Lysosomal Diseases, Neurology Department, Hôpital Pitié-Salpêtrière, Paris, France.

Natalia Shor (N)

Department of Neuroradiology, Pitié-Salpêtrière Hospital, Paris, France.
Sorbonne University, Paris VI University, Paris, France.

Jean-François Benoist (JF)

Metabolic Biochemistry Laboratory, Necker Enfants Malades University Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.

Yann Nadjar (Y)

Neuro-Metabolism Unit, Reference Center for Lysosomal Diseases, Neurology Department, Hôpital Pitié-Salpêtrière, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH